Acute catarrhal infections / Burroughs Wellcome & Co.

  • Burroughs Wellcome & Company
Date:
[between 1930 and 1939?]
Catalogue details

Licence: Public Domain Mark

Credit: Acute catarrhal infections / Burroughs Wellcome & Co. Source: Wellcome Collection.

    7/30 page 3
    After the first injection, the dose is regulated accord- ing to the effect produced. Inthe treatment of acute cold, it is unusual to endeavour to produce any Feaction, but,-in -chronie-conditions: and» {6r prophylactic purposes, some physicians aim at obtaining a definite, though not a severe, reaction consisting of a swelling, which is red and tender, at the site of injection. This may appear in a few hours and subsides after a lapse of from 18 to 24 hours. It is usually accompanied by constitutional symptoms, such as fever and headache. It is generally considered that the best time for injection is in the evening, and the site most favoured is beneath the skin of the abdomen Or upper arm. An ‘AGLa’ Hypodermic Syringe, carefully cleaned and then boiled for a few minutes in water, may be employed. Antiseptic pre- cautions should be observed. (See circular enclosed in packing, which also gives instructions for opening the plial, etc.) Treatment Preparation Wak ‘ WELLCOME’ BRAND CoRYZA VACCINE, No. 4 [a B. W. & Co.] 1 c.c. contains 50 million each of 8. hofmannt, B. friedlinder, M. catarrhalis and Staphylococci, mixed; and 10 million each of Pneumococci and Streptococci, mixed. Hermetically-sealed phials of 1 c.c. The above Vaccine ts also supplied, to special order only, in 10 c.c. and 25 c.c. self-sealing rubber-capped bottles ‘Wellcome’ Brand Vaccines are British-made, under expert supervision and ideal conditions, at The Wellcome Physiological Research Laboratories, Langley Court, Beckenham, Kent (Eng.)
    digitised image 1
    digitised image 2
    digitised image 3